metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Chronic administration of propylthiouracil ameliorates hyperdynamic circulation ...
Journal Information
Vol. 28. Issue 9.
Pages 537-539 (November 2005)
Share
Share
Download PDF
More article options
Vol. 28. Issue 9.
Pages 537-539 (November 2005)
Originales
Full text access
Chronic administration of propylthiouracil ameliorates hyperdynamic circulation in portal hypertensive rats
La administración crónica de propiltiouracilo reduce la circulación hiperdinámica en ratas con hipertensión portal
Visits
3788
L. Albornoza, M. de las Herasb, M. Bildózolab, J.C. Bandic, R.C. Mastaib,
Corresponding author
rmastai@hospitalaleman.com

Correspondencia: Dr. R. Mastai. Unidad de Trasplante. Hospital Alemán. Avda. Pueyrredón, 1640. 1118 Buenos Aires. Argentina.
a Cátedra de Fisiología. Facultad de Medicina. Universidad de Buenos Aires. Buenos Aires. Argentina
b Unidad de Trasplante. Hospital Alemán. Buenos Aires. Argentina
c Sección de Hígado. Servicio de Clínica Médica. Hospital Italiano. Buenos Aires. Argentina
This item has received
Article information
Abstract
Objective

To evaluate the effect of a hypothyroid state, induced by chronic propylthiouracil administration, on splanchnic and systemic hemodynamic parameters in rats with portal hypertension due to portal vein ligation.

Methods

Portal hypertension was induced by surgical stenosis of the portal vein. Cardiac index and portal blood flow were measured using radioactive microspheres. Measurements were performed after treatment with propylthiouracil (1 mg/ml in drinking water) for 5 days.

Results

Propylthiouracil-treated portal hypertensive rats had a lower portal pressure (12.4±1.9 versus 16.3±0.7 mmHg; p<0.05) and portal blood flow (11.6±0.7 versus 13.2±1.3 ml/min/100 g; p<0.05) than non-treated animals. Splanchnic vasoconstriction in treated animals was associated with a higher peripheral vascular resistance (2.3±0.4 versus 1.8±0.3mmHg/ml/min/100 g; p<0.05) than controls.

Conclusion

These results suggest that portal pressure can be lowered by inducing a hypothyroid state by chronic administration of propylthiouracil.

Objetivo

evaluar el efecto del estado hipotiroideo inducido por la administración crónica de propiltiouracilo sobre los parámetros hemodinámicos esplácnicos y sistémicos en ratas con hipertensión portal secundaria a la ligadura de la vena porta.

Métodos

la hipertensión portal fue inducida mediante la ligadura quirúrgica de la vena porta. El índice cardíaco y el flujo sanguíneo portal se determinaron mediante microesferas radioactivas. Las determinaciones se llevaron a cabo tras el tratamiento con propiltiouracilo (1 mg/ml) en el agua durante 5 días.

Resultados

las ratas con hipertensión portal tratadas con propiltiouracilo mostraron una presión portal inferior (12,4±1,9 frente a 16,3±0,7 mmHg; p<0,05) y un flujo sanguíneo portal superior (11,6±0,7 frente a 3,2±1,3 ml/min/100 g; p<0,05) a los de los animales no tratados. La vasoconstricción esplácnica en los animales tratados se asoció a una resistencia vascular periférica (2,3±0,4 frente a 1,8±0,3 mmHg/ml/min/100 g; p<0,05) mayor que la de los animales control.

Conclusión

los resultados obtenidos indican que es possible reducir la presión portal mediante la inducción de un estado hipotiroideo a través de la administración crónica de propiltiouracilo.

Full text is only aviable in PDF
Bibliografía
[1.]
R.J. Groszmann.
Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences.
Hepatology, 20 (1994), pp. 1359-1363
[2.]
J.N. Benoit, J.A. Barrowman, S.L. Harper, P.R. Kvietys, D.N. Granger.
Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension.
Am J Physiol, 247 (1984), pp. 486G-493G
[3.]
M.P. Pizcueta, J.M. Piqué, J. Bosch, B.J.R. Whittle, S. Moncada.
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
Br J Pharmacol, 105 (1992), pp. 184-190
[4.]
N. Hori, R. Wiest, R.J. Groszmann.
Enhanced release of nitric oxide in response to changes in flow and shear stress in the superior mesenteric arteries of portal hypertensive rats.
Hepatology, 28 (1998), pp. 1467-1473
[5.]
C.L. Skelton.
The heart and hyperthyroidism.
N Engl J Med, 307 (1982), pp. 1206-1207
[6.]
D. Lebrec, P. Hillon, C. Munoz, G. Goldfarb, O. Nouel, J.P. Benhamou.
The effect of propranolol on portal hypertension in patients with cirrhosis.
Hepatology, 2 (1982), pp. 523-527
[7.]
J. Bosch, R. Mastai, D. Kravetz, J. Bruix, J. Gaya, J. Rigau, et al.
Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Hepatology, 4 (1984), pp. 1200-1204
[8.]
L. Wortofsky, S.H. Ingbar.
12th ed., McGraw-Hill, (1991),
[9.]
R.J. Groszmann, J. Vorobioff, E. Rilley.
Splanchnic hemodynamics in portal hypertensive rats: measurement with gamma-labeled microspheres.
Am J Physiol, 242 (1982), pp. 156G-160G
[10.]
S. Sánchez, J.C. Bandi, R. Mastai.
Blood flow measurements by the reference sample method with microsphere injection into the aorta: an accurate and easy approach.
Proc Soc Exp Biol Med, 200 (1992), pp. 375-377
[11.]
S. Sánchez, L. Albornoz, J.C. Bandi, S. Gerona, R. Mastai.
Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis.
Eur J Gastroenterol Hepatol, 9 (1997), pp. 27-31
[12.]
Y. Israel, H. Kalunt, H. Orrego, et al.
Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil.
Proc Natl Acad Sci USA, 72 (1975), pp. 1137-1141
[13.]
R.S. Britton, G. Koves, H. Orrego, et al.
Suppression by antithyroid drugs of experimental necrosis after ethanol treatment. Effect on thyroid gland or on peripheral deiodination.
Tox Appl Pharmacol, 51 (1979), pp. 145-155
[14.]
R. Oren, I. Dotan, M. Papa, et al.
Inhibition of experimental induced cirrhosis in rats with hypothyroidism.
[15.]
F.J. Carmichael, H. Orrego, V. Saldivia, Y. Israel.
Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake and unrestrained rats.
Hepatology, 10 (1989), pp. 273-278
[16.]
S. Rojter, J. Tessler, D. Álvarez, et al.
Vasodilatory effects of propylthiouracil in patients with alcoholic cirrhosis.
J Hepatol, 22 (1995), pp. 184-188
[17.]
E. Morkin, I.L. Flink, S. Goldman.
Biochemical and physiologic effects of thyroid hormone on cardiac performance.
Prog Cardiovasc Dis, 25 (1983), pp. 435-465
[18.]
R. Oren, N. Hilzenrat, Y. Maaravi, A. Yaari, E. Sikuler.
Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats.
Dig Dis Sci, 40 (1995), pp. 1941-1945
Copyright © 2005. Elsevier España S.L.. All rights reserved
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos